Wealth Enhancement Advisory Services’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$892K Buy
96,104
+40,269
+72% +$268K ﹤0.01% 2159
2026
Q1
$294K Buy
55,835
+37,662
+207% +$211K ﹤0.01% 2799
2025
Q4
$145K Buy
18,173
+4,954
+37% +$38.8K ﹤0.01% 3355
2025
Q3
$111K Sell
13,219
-267
-2% -$2.08K ﹤0.01% 3317
2025
Q2
$112K Sell
13,486
-3,891
-22% -$28.2K ﹤0.01% 3125
2025
Q1
$138K Buy
17,377
+2,652
+18% +$26.8K ﹤0.01% 2701
2024
Q4
$134K Buy
14,725
+2,662
+22% +$25.7K ﹤0.01% 2761
2024
Q3
$111K Buy
+12,063
New +$99.8K ﹤0.01% 2541
2023
Q4
Sell
-12,009
Closed -$223K 2432
2023
Q3
$223K Buy
+12,009
New +$280K ﹤0.01% 1937

Other funds holding TDOC

Wealth Enhancement Advisory Services's TDOC Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Teladoc Health (TDOC) stake by 72% in Q2 2026, buying an estimated $268K and bringing the position to 96,104 shares worth $892K. The position accounts for ﹤0.01% of the portfolio, ranked #2159.

Wealth Enhancement Advisory Services first reported a position in TDOC in Q3 2023 and has held it in 9 quarters since. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Wealth Enhancement Advisory Services held 96,104 shares of Teladoc Health worth $892K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 40,269 Teladoc Health shares in Q2 2026, an estimated $268K.
  • Teladoc Health made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2159 holding.
  • Wealth Enhancement Advisory Services first reported a position in Teladoc Health in Q3 2023 and has held it in 9 quarters since.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.